{"id":1180,"date":"2020-09-30T00:00:00","date_gmt":"2020-09-30T00:00:00","guid":{"rendered":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2020\/09\/30\/ect-may-reduce-suicide-risk-in-patients-with-bipolar-depression\/"},"modified":"2020-10-01T16:10:05","modified_gmt":"2020-10-01T16:10:05","slug":"ect-may-reduce-suicide-risk-in-patients-with-bipolar-depression","status":"publish","type":"post","link":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2020\/09\/30\/ect-may-reduce-suicide-risk-in-patients-with-bipolar-depression\/","title":{"rendered":"ECT May Reduce Suicide Risk in Patients With Bipolar Depression"},"content":{"rendered":"<h3>Authors of cohort study report 84.4 percent decrease in suicidality after electroconvulsive therapy<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>WEDNESDAY, Sept. 30, 2020 (HealthDay News) &#8212; Electroconvulsive therapy (ECT) may help treat features of bipolar depression, including suicidality, according to study results partially published earlier this year in the <i>The World Journal of Biological Psychiatry<\/i> and presented at the annual congress of the European College of Neuropsychopharmacology, held virtually from Sept. 12 to 15.<\/p>\n<p>Giulio E. Brancati, Ph.D., from the University of Pisa in Italy, and colleagues examined the differential impact of ECT on single depressive and mixed symptoms in a cohort of 670 bipolar adult patients admitted between January 2006 and July 2019.<\/p>\n<p>The researchers found that response rates were higher than 80 percent for all the psychopathological constructs investigated; the highest rates of response were seen for motor hyperactivity, grandiosity, excitement, tension, suicidality, bizarre behavior, and guilt. The highest remission rate was seen for suicidality: 77 patients (84.4 percent) were at high risk before treatment compared with two patients after treatment. Severe mannerisms and posturing, uncooperativeness, hostility, excitement, motor hyperactivity, and suspiciousness were highly remitting (>60 percent); slightly remitting features included depression, blunted affect, unusual thought, somatic concern, anxiety, and self-neglect (<40 percent). After ECT, all clinical feature scores were significantly decreased; the largest effects were seen for depression, anxiety, self-neglect, guilt, suicidality, tension, blunted affect, and motor retardation.<\/p>\n<p>&#8220;ECT is used for major depression, but much less so for the other phases of bipolar disorder, especially for so-called mixed states, which have a lower visibility,&#8221; Brancati said in a statement. &#8220;These patients need to be given a chance via receiving the right treatment.&#8221;<\/p>\n<p><a href=\"https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/15622975.2020.1770860\" target=\"_new\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><a href=\"https:\/\/www.ecnp.eu\/Congress2020\/ECNPcongress\" target=\"_new\" rel=\"noopener noreferrer\">More Information<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2020 <a href=\"http:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener noreferrer\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Authors of cohort study report 84.4 percent decrease in suicidality after electroconvulsive therapy<\/p>\n","protected":false},"author":4,"featured_media":1224,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[85],"tags":[],"acf":[],"_links":{"self":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/1180"}],"collection":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/comments?post=1180"}],"version-history":[{"count":0,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/1180\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/media\/1224"}],"wp:attachment":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/media?parent=1180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/categories?post=1180"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/tags?post=1180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}